Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (271-280 of 1,124) with videos related to

Pageof 113
Sort By:
European Urology|September 23, 2019
Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate CancerMary-Ellen Taplin, Emmanuel S Antonarakis, Karen J Ferrante, et al.
Prostate Cancer and Prostatic Diseases|November 8, 2019
Prostate cancer characteristics and cancer-specific mortality of Native American patientsMarina Deuker, Sophie Knipper, Angela Pecoraro, et al.
Cancers|November 3, 2020
PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical RecurrenceSylvie Clairefond, Benjamin Péant, Véronique Ouellet, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 26, 2018
The burden of symptomatic skeletal events in castrate-resistant prostate cancer patients with bone metastases at three Canadian uro-oncology centresFred Saad, Neil E Fleshner, Alan So, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2020
Newly Diagnosed High-Risk Prostate Cancer in an Era of Rapidly Evolving New Imaging: How Do We Treat?Maha Hussain, Daniel Lin, Fred Saad, et al.
Cancers|September 9, 2023
Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate CancerSoumyajit Roy, Yilun Sun, Christopher J D Wallis, et al.
Psycho-Oncology|February 15, 2019
Psychosocial adjustment to a prostate cancer diagnosis in a cohort of radical prostatectomy patients in Quebec, CanadaMichel D Wissing, Simone Chevalier, Ana O'Flaherty, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 31, 2022
UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imagingRoss J Mason, Karim Marzouk, Antonio Finelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Sarcopenia during androgen-deprivation therapy for prostate cancerMatthew R Smith, Fred Saad, Blair Egerdie, et al.
European Urology Oncology|August 22, 2025
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate CancerFred Saad, Alberto Briganti, Kunhi Parambath Haresh, et al.
Pageof 113

Showing results (271-280 of 1,124) with videos related to

Sort By:
Pageof 113
European Urology|September 23, 2019
Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate CancerMary-Ellen Taplin, Emmanuel S Antonarakis, Karen J Ferrante, et al.
Prostate Cancer and Prostatic Diseases|November 8, 2019
Prostate cancer characteristics and cancer-specific mortality of Native American patientsMarina Deuker, Sophie Knipper, Angela Pecoraro, et al.
Cancers|November 3, 2020
PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical RecurrenceSylvie Clairefond, Benjamin Péant, Véronique Ouellet, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 26, 2018
The burden of symptomatic skeletal events in castrate-resistant prostate cancer patients with bone metastases at three Canadian uro-oncology centresFred Saad, Neil E Fleshner, Alan So, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2020
Newly Diagnosed High-Risk Prostate Cancer in an Era of Rapidly Evolving New Imaging: How Do We Treat?Maha Hussain, Daniel Lin, Fred Saad, et al.
Cancers|September 9, 2023
Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate CancerSoumyajit Roy, Yilun Sun, Christopher J D Wallis, et al.
Psycho-Oncology|February 15, 2019
Psychosocial adjustment to a prostate cancer diagnosis in a cohort of radical prostatectomy patients in Quebec, CanadaMichel D Wissing, Simone Chevalier, Ana O'Flaherty, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 31, 2022
UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imagingRoss J Mason, Karim Marzouk, Antonio Finelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Sarcopenia during androgen-deprivation therapy for prostate cancerMatthew R Smith, Fred Saad, Blair Egerdie, et al.
European Urology Oncology|August 22, 2025
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate CancerFred Saad, Alberto Briganti, Kunhi Parambath Haresh, et al.
Pageof 113